Literature DB >> 27296288

Nonreversible MAIT cell-dysfunction in chronic hepatitis C virus infection despite successful interferon-free therapy.

Julia Hengst1,2, Benedikt Strunz1, Katja Deterding2, Hans-Gustaf Ljunggren1, Edwin Leeansyah1,3, Michael P Manns2,4, Markus Cornberg2,4, Johan K Sandberg1, Heiner Wedemeyer2,4, Niklas K Björkström5.   

Abstract

Immune exhaustion is a hallmark of chronic viral infections. However, pathogen eradication can result in reinvigorated immune responses. Indeed, this was recently suggested for antigen-specific CD8(+) T cells and NK cells in HCV-infected patients receiving an interferon-free treatment regimen. Mucosal-associated invariant T (MAIT) cells are evolutionarily conserved innate-like effector T cells. Here, we show that MAIT cells are severely diminished in frequency in chronic HCV-infection, and in this regard the most affected immune cell type in peripheral blood of humans with this disease. Residual MAIT cells show an activated phenotype with high expression of granzyme B, HLA-DR, PD-1, and CD69 as well as altered transcription factor expression and suppressed responsiveness to MR1-dependent antigen stimulation. In contrast to other immune cells, MAIT cells are not reinvigorated after successful HCV-clearance using interferon-free therapy. The present results hence demonstrate persistent immune cell-dysfunction in humans despite successful elimination of a chronic pathogen.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Chronic infection; HCV; Immune exhaustion; Interferon-free therapy; MAIT cells

Mesh:

Substances:

Year:  2016        PMID: 27296288     DOI: 10.1002/eji.201646447

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  68 in total

1.  Multiple layers of heterogeneity and subset diversity in human MAIT cell responses to distinct microorganisms and to innate cytokines.

Authors:  Joana Dias; Edwin Leeansyah; Johan K Sandberg
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-19       Impact factor: 11.205

Review 2.  The role of mucosal-associated invariant T cells in infectious diseases.

Authors:  Emily B Wong; Thumbi Ndung'u; Victoria O Kasprowicz
Journal:  Immunology       Date:  2016-10-26       Impact factor: 7.397

3.  Chronic hepatitis delta virus infection leads to functional impairment and severe loss of MAIT cells.

Authors:  Joana Dias; Julia Hengst; Tiphaine Parrot; Edwin Leeansyah; Sebastian Lunemann; David F G Malone; Svenja Hardtke; Otto Strauss; Christine L Zimmer; Lena Berglin; Thomas Schirdewahn; Sandra Ciesek; Nicole Marquardt; Thomas von Hahn; Michael P Manns; Markus Cornberg; Hans-Gustaf Ljunggren; Heiner Wedemeyer; Johan K Sandberg; Niklas K Björkström
Journal:  J Hepatol       Date:  2019-05-14       Impact factor: 25.083

4.  Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver Fibrosis.

Authors:  Daniel Sepulveda-Crespo; Salvador Resino; Isidoro Martinez
Journal:  Drugs       Date:  2021-01-05       Impact factor: 9.546

Review 5.  Insights From Antiviral Therapy Into Immune Responses to Hepatitis B and C Virus Infection.

Authors:  Barbara Rehermann; Robert Thimme
Journal:  Gastroenterology       Date:  2018-09-26       Impact factor: 22.682

6.  Intra-Hepatic Depletion of Mucosal-Associated Invariant T Cells in Hepatitis C Virus-Induced Liver Inflammation.

Authors:  Fabian J Bolte; Ashley C O'Keefe; Lauren M Webb; Elisavet Serti; Elenita Rivera; T Jake Liang; Marc Ghany; Barbara Rehermann
Journal:  Gastroenterology       Date:  2017-08-02       Impact factor: 22.682

7.  Hepatocellular metastasis recurrence in liver transplant after treatment with direct antiviral agents.

Authors:  Silvia Maier; Debora Donnini; Laura De Luca; Claudio Avellini; Leonardo Alberto Sechi; Giorgio Soardo
Journal:  Clin J Gastroenterol       Date:  2019-08-13

Review 8.  Designing an HCV vaccine: a unique convergence of prevention and therapy?

Authors:  Christopher M Walker
Journal:  Curr Opin Virol       Date:  2017-05-25       Impact factor: 7.090

9.  Activation and Impaired Tumor Necrosis Factor-α Production of Circulating Mucosal-Associated Invariant T Cells in Patients with Trauma.

Authors:  Young-Goun Jo; Hye-Mi Jin; Young-Nan Cho; Jung-Chul Kim; Seung-Jung Kee; Yong-Wook Park
Journal:  J Innate Immun       Date:  2019-05-14       Impact factor: 7.349

10.  Time course of cellular HIV-DNA and low-level HIV viremia in HIV-HCV co-infected patients whose HCV infection had been successfully treated with directly acting antivirals.

Authors:  Saverio G Parisi; Samantha Andreis; Monica Basso; Silvia Cavinato; Renzo Scaggiante; Marzia Franzetti; Massimo Andreoni; Giorgio Palù; Anna Maria Cattelan
Journal:  Med Microbiol Immunol       Date:  2017-09-01       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.